Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
ALLEGRO 临床试验项目中口服 JAK3/TEC 家族激酶抑制剂 Ritlecitinib 治疗斑秃的综合安全性分析
期刊:American Journal of Clinical Dermatology
影响因子:
doi:10.1007/s40257-024-00846-3
Brett King, Jennifer Soung, Christos Tziotzios, Lidia Rudnicka, Pascal Joly, Melinda Gooderham, Rodney Sinclair, Natasha A Mesinkovska, Carle Paul, Yankun Gong, Susan D Anway, Helen Tran, Robert Wolk, Samuel H Zwillich, Alexandre Lejeune2